CiT Research Development vs Ebitda Analysis

CINT Stock

USD 6.73 0.10 1.46%

CiT financial indicator trend analysis is way more than just evaluating CiT Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CiT Inc is a good investment. Please check the relationship between CiT Research Development and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CiT Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Research Development vs Ebitda

Research Development vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CiT Inc Research Development account and Ebitda. At this time, the significance of the direction appears to have pay attention.

The correlation between CiT's Research Development and Ebitda is -0.95. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebitda in the same time period over historical financial statements of CiT Inc, assuming nothing else is changed. The correlation between historical values of CiT's Research Development and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of CiT Inc are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Research Development i.e., CiT's Research Development and Ebitda go up and down completely randomly.

Correlation Coefficient

-0.95

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Research Development

Ebitda

Most indicators from CiT's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CiT Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CiT Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Enterprise Value is likely to gain to about 6 B in 2024, whereas Tax Provision is likely to drop slightly above 72.6 M in 2024.

	2021	2022	2023	2024 (projected)
EBIT	240.1M	274.1M	292.8M	307.5M
Other Operating Expenses	1.2B	1.9B	1.9B	2.0B

Ebit Other Operating Expenses

CiT fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Other Current Assets	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Good Will	Common Stock Shares Outstanding
Other Current Liab		0.87	0.72	-0.5	0.7	0.56	0.08	0.87	0.85	0.75	0.85	-0.28	0.81	0.88	0.86	0.86	0.62	0.65	0.84	0.83	0.86	0.69	0.85	0.51	0.87	0.21
Total Current Liabilities	0.87		0.92	-0.61	0.94	0.88	-0.36	1.0	0.98	0.94	0.84	-0.47	0.91	0.94	0.94	0.94	0.86	0.71	0.92	0.92	0.92	0.89	0.93	0.61	0.92	0.53
Other Liab	0.72	0.92		-0.85	0.97	0.86	-0.56	0.94	0.86	0.94	0.63	-0.61	0.72	0.88	0.88	0.89	0.74	0.86	0.87	0.85	0.93	0.99	0.87	0.37	0.92	0.75
Net Tangible Assets	-0.5	-0.61	-0.85		-0.74	-0.49	0.5	-0.64	-0.52	-0.64	-0.2	0.5	-0.33	-0.59	-0.58	-0.59	-0.29	-0.89	-0.57	-0.6	-0.74	-0.89	-0.57	0.14	-0.74	-0.83
Retained Earnings	0.7	0.94	0.97	-0.74		0.9	-0.6	0.95	0.9	0.9	0.66	-0.5	0.79	0.85	0.85	0.86	0.8	0.76	0.83	0.9	0.87	0.96	0.84	0.41	0.87	0.74
Accounts Payable	0.56	0.88	0.86	-0.49	0.9		-0.67	0.87	0.87	0.92	0.73	-0.57	0.8	0.82	0.85	0.85	0.95	0.6	0.84	0.8	0.78	0.81	0.84	0.66	0.77	0.57
Other Assets	0.08	-0.36	-0.56	0.5	-0.6	-0.67		-0.35	-0.34	-0.44	0.0	0.34	-0.26	-0.24	-0.29	-0.31	-0.47	-0.44	-0.28	-0.39	-0.32	-0.59	-0.28	0.01	-0.31	-0.77
Net Receivables	0.87	1.0	0.94	-0.64	0.95	0.87	-0.35		0.96	0.95	0.84	-0.51	0.88	0.95	0.95	0.95	0.84	0.73	0.93	0.91	0.93	0.9	0.94	0.6	0.93	0.54
Other Current Assets	0.85	0.98	0.86	-0.52	0.9	0.87	-0.34	0.96		0.9	0.85	-0.41	0.93	0.91	0.91	0.91	0.88	0.6	0.89	0.96	0.87	0.83	0.9	0.65	0.87	0.47
Other Stockholder Equity	0.75	0.94	0.94	-0.64	0.9	0.92	-0.44	0.95	0.9		0.82	-0.72	0.77	0.96	0.96	0.96	0.89	0.75	0.97	0.83	0.93	0.89	0.96	0.66	0.93	0.52
Total Current Assets	0.85	0.84	0.63	-0.2	0.66	0.73	0.0	0.84	0.85	0.82		-0.46	0.82	0.9	0.9	0.9	0.86	0.47	0.9	0.77	0.79	0.55	0.9	0.86	0.8	0.0
Common Stock	-0.28	-0.47	-0.61	0.5	-0.5	-0.57	0.34	-0.51	-0.41	-0.72	-0.46		-0.13	-0.65	-0.65	-0.65	-0.55	-0.59	-0.68	-0.37	-0.64	-0.57	-0.67	-0.46	-0.64	-0.29
Property Plant Equipment	0.81	0.91	0.72	-0.33	0.79	0.8	-0.26	0.88	0.93	0.77	0.82	-0.13		0.79	0.8	0.79	0.83	0.45	0.77	0.85	0.72	0.68	0.78	0.65	0.72	0.35
Total Assets	0.88	0.94	0.88	-0.59	0.85	0.82	-0.24	0.95	0.91	0.96	0.9	-0.65	0.79		1.0	1.0	0.85	0.77	0.99	0.88	0.97	0.83	1.0	0.67	0.97	0.35
Short Long Term Debt Total	0.86	0.94	0.88	-0.58	0.85	0.85	-0.29	0.95	0.91	0.96	0.9	-0.65	0.8	1.0		1.0	0.88	0.77	1.0	0.88	0.97	0.83	1.0	0.67	0.97	0.36
Total Stockholder Equity	0.86	0.94	0.89	-0.59	0.86	0.85	-0.31	0.95	0.91	0.96	0.9	-0.65	0.79	1.0	1.0		0.87	0.79	1.0	0.89	0.97	0.84	1.0	0.66	0.97	0.37
Property Plant And Equipment Net	0.62	0.86	0.74	-0.29	0.8	0.95	-0.47	0.84	0.88	0.89	0.86	-0.55	0.83	0.85	0.88	0.87		0.49	0.87	0.8	0.76	0.68	0.87	0.82	0.76	0.31
Current Deferred Revenue	0.65	0.71	0.86	-0.89	0.76	0.6	-0.44	0.73	0.6	0.75	0.47	-0.59	0.45	0.77	0.77	0.79	0.49		0.77	0.7	0.9	0.87	0.77	0.08	0.89	0.59
Net Debt	0.84	0.92	0.87	-0.57	0.83	0.84	-0.28	0.93	0.89	0.97	0.9	-0.68	0.77	0.99	1.0	1.0	0.87	0.77		0.85	0.96	0.81	1.0	0.68	0.96	0.33
Cash	0.83	0.92	0.85	-0.6	0.9	0.8	-0.39	0.91	0.96	0.83	0.77	-0.37	0.85	0.88	0.88	0.89	0.8	0.7	0.85		0.88	0.84	0.86	0.47	0.88	0.5
Non Current Assets Total	0.86	0.92	0.93	-0.74	0.87	0.78	-0.32	0.93	0.87	0.93	0.79	-0.64	0.72	0.97	0.97	0.97	0.76	0.9	0.96	0.88		0.9	0.97	0.47	1.0	0.47
Non Currrent Assets Other	0.69	0.89	0.99	-0.89	0.96	0.81	-0.59	0.9	0.83	0.89	0.55	-0.57	0.68	0.83	0.83	0.84	0.68	0.87	0.81	0.84	0.9		0.82	0.27	0.89	0.81
Long Term Debt	0.85	0.93	0.87	-0.57	0.84	0.84	-0.28	0.94	0.9	0.96	0.9	-0.67	0.78	1.0	1.0	1.0	0.87	0.77	1.0	0.86	0.97	0.82		0.68	0.97	0.34
Cash And Short Term Investments	0.51	0.61	0.37	0.14	0.41	0.66	0.01	0.6	0.65	0.66	0.86	-0.46	0.65	0.67	0.67	0.66	0.82	0.08	0.68	0.47	0.47	0.27	0.68		0.48	-0.16
Good Will	0.87	0.92	0.92	-0.74	0.87	0.77	-0.31	0.93	0.87	0.93	0.8	-0.64	0.72	0.97	0.97	0.97	0.76	0.89	0.96	0.88	1.0	0.89	0.97	0.48		0.46
Common Stock Shares Outstanding	0.21	0.53	0.75	-0.83	0.74	0.57	-0.77	0.54	0.47	0.52	0.0	-0.29	0.35	0.35	0.36	0.37	0.31	0.59	0.33	0.5	0.47	0.81	0.34	-0.16	0.46

Click cells to compare fundamentals

CiT Account Relationship Matchups

CiT fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	165.4M	186.4M	248.4M	523.2M	282.5M	166.1M
Total Current Liabilities	227.4M	311.0M	549.0M	755.2M	729.9M	766.4M
Other Liab	2.3M	1.1M	39.1M	149.2M	171.6M	180.1M
Net Tangible Assets	91.2M	180.3M	350.5M	(412.7M)	(371.4M)	(352.9M)
Retained Earnings	32.8M	109.3M	126.0M	251.9M	354.2M	372.0M
Accounts Payable	8.6M	15.3M	82.5M	35.1M	110.1M	115.6M
Other Assets	31.8M	23.8M	41.1M	83.8M	(126.9M)	(120.6M)
Net Receivables	167.1M	250.0M	485.5M	718.9M	660.6M	693.7M
Other Current Assets	5.7M	24.8M	30.9M	36.7M	36.7M	38.5M
Other Stockholder Equity	(32.8M)	(109.3M)	790.0M	907.8M	980.9M	1.0B
Total Current Assets	255.2M	434.6M	1.5B	1.1B	912.1M	519.9M
Property Plant Equipment	101.8M	108.5M	131.5M	111.5M	128.2M	134.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for CiT Stock Analysis

When running CiT's price analysis, check to measure CiT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CiT is operating at the current time. Most of CiT's value examination focuses on studying past and present price action to predict the probability of CiT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CiT's price. Additionally, you may evaluate how the addition of CiT to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC